Ciechomska et al. assessed serum levels of miR-5196 in 10 RA, 13 Ankylosing Spondylitis (AS), and 12 healthy individuals to evaluate its potential as a predictor of anti-TNFα therapy. Here, TNF is linked to ankylosing spondylitis.